Institution statistics

MAX DELBRUECK CENTRUM FÜR MOLEKULARE MEDIZIN - Germany 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:600-700
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:300-400
Total Number of Projects:700-800
Networking Rank (Reputation):> 1000
2017
Criterium:Position:
Overall Score:400-500
Total Project Funding per Partner:200-300
Total Number of Projects:300-400
Networking Rank (Reputation):600-700
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2013
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:400-500
Total Number of Projects:69
Total Project Funding:700-800
Partner Constancy:58
Project Leadership Index:69
Diversity Index:32
2012
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:100-200
Total Number of Projects:62
Total Project Funding:700-800
Networking Rank (Reputation):800-900
Networking Rank (Reputation):800-900
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:200-300
Total Number of Projects:700-800
Total Project Funding:800-900
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:700-800
2010
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:200-300
Total Number of Projects:300-400
Total Project Funding:200-300
Networking Rank (Reputation):900-1000
Partner Constancy:100-200
Project Leadership Index:20
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:300-400
Total Number of Projects:500-600
Total Project Funding:600-700
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:800-900
2008
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:600-700
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:300-400
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:800-900
Total Number of Projects:900-1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 49
As coordinator: 1
As participant: 35
Sole participant: 13
Coordinator / Participant Ratio: 0.03*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 2.319.514 0 2.319.514 1
2018 2.500.000 4.062.700 2.752.788 1 1
2016 0 1.999.877 1.999.877 1
2015 0 1.993.421 0 1
2014 100.000 10.397.601 5.503.601 1 3
2013 268.794 7.106.124 2.724.421 2 3
2012 167.390 11.375.174 4.725.348 1 4
2011 245.940 12.950.836 4.433.852 1 3
2010 10.923.322 27.888.785 5.262.233 4 4
2009 100.000 16.109.225 2.175.907 1 4
2008 0 6.920.485 1.232.458 3
2006 0 12.000.000 279.070 1
2005 148.588 600.424 173.606 1 1
2004 1.044.333 37.459.725 3.404.195 1 6
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE7
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE6
EUROPEAN MOLECULAR BIOLOGY LABORATORY6
KAROLINSKA INSTITUTE6
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR5
UNIVERSITY COLLEGE LONDON5
UNIVERSITY OF COPENHAGEN5
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV4
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE4
THE UNIVERSITY OF EDINBURGH4
CHARITE UNIVERSITAETSMEDIZIN BERLIN3
COMMISSARIAT A L'ENERGIE ATOMIQUE3
DEUTSCHES KREBSFORSCHUNGSZENTRUM3
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN3
MEDICAL RESEARCH COUNCIL3
USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYSKUMNA INSTITUCE3
VIB3
ACIES SAS2
AGENDIA BV2
ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRL ALTA2
CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS2
CONSIGLIO NAZIONALE DELLE RICERCHE2
DANMARKS TEKNISKE UNIVERSITET2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH2
GENETHON2
GENOME RESEARCH2
GENOSAFE SAS2
GOETEBORGS UNIVERSITET2
HELMHOLTZZENTRUM FUER INFEKTIONSFORSCHUNG2
LEIDEN UNIVERSITY MEDICAL CENTER2
LUDWIG INSTITUT FUER KREBSFORSCHUNG2
LUDWIG INSTITUT FUER KREBSFORSCHUNG2
LUNDS UNIVERSITET2
MEDIZINISCHE HOCHSCHULE HANNOVER2
MOLECULAR MEDICINE2
NOVARTIS FORSCHUNGSSTIFTUNG ZWEIGNIEDERLASSUNG FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH2
PAUL EHRLICH INSTITUT2
ROYAL HOLLOWAY AND BEDFORD NEW COLLEGE2
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS2
STICHTING VU2
SYNAPTOLOGICS BV2
SYNOME2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD2
THE NETHERLANDS CANCER INSTITUTE / ANTONI VAN LEEUWENHOEK HOSPITAL2
UNIVERSITAETSKLINIKUM HEIDELBERG2
UNIVERSITY OF HELSINKI2
UNIVERSITY OF OSLO2
VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG2
VRIJE UNIVERSITEIT BRUSSEL2
VTT TECHNICAL RESEARCH CENTRE OF FINLAND2
WEIZMANN INSTITUTE OF SCIENCE2
3P BIOPHARMACEUTICALS SL1
A N BAKH INSTITUTE OF BIOCHEMISTRY OF THE RUSSIAN ACADEMY OF SCIENCES1
ACADEMISCH ZIEKENHUIS LEIDEN1
ACCIONA INFRAESTRUCTURAS1
AFRICAN TECHNOLOGY POLICY STUDIES NETWORK1
AGRICULTURAL BIOTECHNOLOGY CENTER1
ALGONOMICS NV1
AMSTERDAM BIOTHERAPEUTICS UNIT1
ARTTIC1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ATLAS BIOLABS1
AVENTIS PHARMA RECHERCHEDEVELOPPEMENT1
BASF SE1
BEACTICA AB1
BEATSON INSTITUTE FOR CANCER RESEARCH1
BIOALLIANCE PHARMA1
BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING1
BIONEER1
BIORELIANCE1
BIOTALENTUM TUDASFEJLESZTO KFT1
BIOVERTIS INFORMATION DRIVEN DRUG DESIGN1
BIRKBECK COLLEGE UNIVERSITY OF LONDON1
BRAINWAVE DISCOVERY LIMITED1
BUDAPESTI MUSZAKI ES GAZDASAGTUDOMANYI EGYETEM1
BUNDESMINISTERIUM FUER BILDUNG UND FORSCHUNG1
CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST1
CELLGENIX TECHNOLOGIE TRANSFER1
CELLOGIC1
CEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN1
CENTRE DE REGULACIO GENOMICA1
CENTRE EUROPEAN FOR RESEARCH IN BIOLOGY AND MEDICINE1
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE1
CENTRE FOR WORLD SOLIDARITY CWS1
CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES1
CENTRO DE INVESTIGACIONES ENERGETICAS MEDIOAMBIENTALES Y TECNOLOGICAS1
CLEAN CELLS1
COLOROBBIA CONSULTING1
COLOROBBIA ITALIA1
COMMISSION OF THE EUROPEAN COMMUNITIES DIRECTORATE GENERAL JOINT RESEARCH CENTRE JRC1
CONSORZIO INTERDISCIPLINARE DI STUDI BIOMOLECOLARI ED APPLICAZIONI INDUSTRIALI SCRL1
CONSORZIO INTERUNIVERSITARIO BIOTECNOLOGIE1
CONSORZIO INTERUNIVERSITARIO RISONANZE MAGNETICHE DI METALLOPROTEINE PARAMAGNETICHE1
CONSORZIO VENEZIA RICERCHE1
DAI KUISHENG1
DEVELOGEN AKTIENGESELLSCHAFT FUER ENTWICKLUNGSBIOLOGISCHE FORSCHUNG1
DIAGENODE1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
EBERHARDKARLS UNIVERSITAET TUEBINGEN1
Constancy:

Total number of partners:393

Partner loyalty:
Frequent Partner: (> 2 projects): 73
Rare Partner: 320

Frequent / Rare Partner Ratio: 0.23

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES26
RTD HORIZONTAL TOPICS15
SOCIAL AND ECONOMIC CONCERNS11
MEASUREMENTS AND STANDARDS1
INDUSTRY AND TECHNOLOGY1

Project overview:

Start dateProjectacronymrolefundingpartners
2019-01-01Novel Coding Factors in Heart Disease CodingHeartcoordinator2.319.5141
2018-11-01Predictive Epigenetics: Fusing Theory and Experiment PEP-NETparticipant4.062.70016
2018-07-01Tethers for sensory mechanotransduction: from molecules to perception SENSATIONAL TETHERScoordinator2.500.0001
2016-09-01Neural mechanisms of multisensory perceptual binding ACoolTouchparticipant1.999.8771
2015-09-01DNA end protection in Immunity and Cancer DNAendProtectionparticipant1.993.4211
2014-07-01Structural basis of mitochondrial inner membrane shape and dynamic MITOSHAPEparticipant1.999.9721
2014-05-01Dissecting the mechanisms of miRNA function MIRFUNCTIONcoordinator100.0001
2014-02-01METABOLIC BASIS OF NEURODEGENERATIVE DISEASE BEYONDparticipant2.415.2291
2014-02-01Biomarker Development for Postoperative Cognitive Impairment in the Elderly BIOCOGparticipant5.982.40012
2013-10-01The European non-coding RNA network RNATRAINparticipant3.474.40011
2013-06-01Condition specific RNA Regulatory Maps RNAREGMAPcoordinator168.7941
2013-06-01Fast two-photon in vivo imaging and stimulation with simultaneous three-dimensional random-access scanning in multiple brain regions 3x3D Imagingparticipant1.690.9996
2013-04-01Characterization of direct reprogramming-regulating factors LIN-53 and USP-48 REPROL53U48coordinator100.0001
2013-01-01Impact of stress-induced transposon activities on human disease TRANSPOSOSTRESSparticipant1.940.7251
2012-11-01"Transposon-based, targeted ex vivo gene therapy to treat age-related macular degeneration (AMD)" TARGETAMDparticipant5.976.29815
2012-07-01Function of the transcription factors Olig3 and Lbx1 in brainstem respiratory nuclei Olig3-Lbx1 breathingcoordinator167.3901
2012-04-01Molecular exploitation of an extremophile mammal EXTREMOPHILE MAMMALparticipant2.498.9601
2012-02-01Peripheral and Central Mechanisms of Temperature Detection and Core Body Thermoregulation ThermoRegparticipant1.400.7252
2012-01-01A systems and targeted approach to alternative splicing in the developing and diseased heart: Translating basic cell biology to improved cardiac function CardioSpliceparticipant1.499.1911
2011-11-01Managing Risks of Nanoparticles MARINAparticipant8.999.92451
2011-07-01Modeling lymphoma pathogenesis in mice - from basic mechanisms to pre-clinical models LYMPHOMAparticipant2.487.7871
2011-02-01Brain states, synapses and behaviour BrainStatesparticipant1.463.1251
2011-02-01Capturing kinase-substrate pairs in intact mammalian cells by using unnatural amino acid mutagenesis and photocrosslinking Kinase crosslinkingcoordinator245.9401
2010-11-01European Infrastructure of Open Screening Platforms for Chemical Biology EU-OPENSCREENparticipant3.700.00023
2010-11-01Molecular Mechanisms Regulating Pancreatic Islet Vascularization ISLETVASCparticipant1.496.2571
2010-08-01Mechanotransduction in situ TOUCH IN SITUcoordinator161.6611
2010-07-01Synaptic Systems: dissecting brain function in health and disease SYNSYSparticipant10.739.83718
2010-07-01Investigation of the role of CXCL5/CXCR1 pathway in atherosclerosis Atherochemokinecoordinator161.6611
2010-04-01European large-scale functional genomics in the rat for translational research EURATRANScoordinator10.500.00019
2010-01-01Regulation and function of the E3 ubiquitin ligases Muscle RING finger 1 and 3 in cardiac hypertrophy MuRF and hypertrophycoordinator100.0001
2010-01-01European Consortium on Synaptic Protein Networks in Neurological and Psychiatric Diseases EUROSPINparticipant11.952.69118
2009-11-01Mechanisms underlying cell fate decision between pancreas and liver HEPATOPANCREATICparticipant1.186.7451
2009-10-01Advanced Teaching and TRaining for Adoptive Cell Therapy ATTRACTparticipant2.838.53914
2009-07-01Novel signals guiding endodermal progenitor cells toward a pancreatic fate ENDOPANCcoordinator100.0001
2009-01-01Comparative stem cell research in mouse and humans INDUSTEMparticipant902.5303
2009-01-01Persisting Transgenesis PERSISTparticipant11.181.41129
2008-10-01Evolution of gene regulatory networks in animal development EVONETparticipant2.650.0007
2008-04-01HGF/SF and MET in metastasis SFMETparticipant2.927.0084
2008-03-01Science, etchics and technological responsibility in developing and emerging countries SET-DEVparticipant1.343.47711
2006-04-01European network for the advancement of clinical gene transfer and therapy CLINIGENEparticipant12.000.00043
2005-10-01Chimeras and Hybrids in comparative European and International Research - natural scientific, ethical, philosophical and legal aspects IMGBCHIMERASHYBRIDSparticipant600.42424
2005-01-01Function of C/EBP beta in bone development and bone tumourigenesis C/EBP BETA AND BONEcoordinator148.5881
2004-11-01High throughput development of drugs for immunotherapy of autoimmune diseases DRUGS FOR THERAPYparticipant3.009.72512
2004-09-01A systematic approach to find new cancer molecules: an enhancer trap screen to identify ES-TRAPcoordinator1.044.3331
2004-06-01Translational and Functional Onco-Genomics: from cancer-oriented genomic screenings to new diagnostic tools and improved cancer treatment. TRANSFOGparticipant6.000.00022
2004-03-01Functional Genomics in Engineered ES cells FUNGENESparticipant8.500.00017
2004-03-01The Alternate Transcript Diversity Project ATDparticipant2.300.0009
2004-01-01European integrated project on spinocerebellar ataxias (EUROSCA): Pathogenesis, genetics, animal models and therapy EUROSCAparticipant9.450.00021
2004-01-01Identification of novel targets for cancer therapy INTACTparticipant8.200.00013

Alias institution names:
  • MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN
  • MAXDELBRUCKCENTRUM FUR MOLEKULAREMEDIZIN

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum